Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
terpene-enriched medical cannabis oil
- Development stage
- Phase 3
- Lead developer
- Bazelet Group
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Terpene-enriched medical cannabis oil is a standardized, patented botanical formulation developed by Bazelet Group in collaboration with Hadassah Hebrew University Medical Center. It consists of medical cannabis oil (containing cannabinoids such as THC and CBD) enriched with a precise, optimized profile of specific cannabis-derived terpenes (such as myrcene, pinene, limonene, and beta-caryophyllene) to restore the volatile terpenes lost during standard extraction processes. This formulation leverages the 'entourage effect'—the synergistic interaction between cannabinoids and terpenes—to enhance therapeutic efficacy. It is primarily being evaluated in Phase 2 clinical trials for the management of chronic pain, acute radicular pain, attention-deficit/hyperactivity disorder (ADHD), and autism spectrum disorder (ASD), aiming to improve pain relief and reduce opioid dependence.
- Brand names
- BCANNBCANN SilverBCANN SpecialsFemmican
- Other names
- terpene-enhanced cannabinoid formulationterpene-enriched cannabinoid compositionterpene-enriched cannabis oil
02
Targets
CNR1 (Cannabinoid receptor 1)CNR2 (Cannabinoid receptor type 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on terpene-enriched medical cannabis oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on terpene-enriched medical cannabis oil.